0.00
100.00%
-7.15
Handel nachbörslich:
7.14
7.14
+
Finanzdaten der G 1 Therapeutics Inc-Aktie (GTHX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
2.67%
14.48
|
14.87 | 12.30 | 42.39 | 12.95 |
Operating Expenses
|
1.17%
23.52
|
23.80 | 28.67 | 30.88 | 38.69 |
Benefits Costs and Expenses |
0.62%
24.70
|
24.85 | 29.60 | 32.37 | 40.54 |
Costs And Expenses |
0.62%
24.70
|
24.85 | 29.60 | 32.37 | 40.54 |
Operating Income/Loss |
1.33%
-9.048
|
-8.929 | -16.37 | 11.52 | -25.75 |
Income/Loss From Continuing Operations Before Tax |
2.44%
-10.22
|
-9.976 | -17.30 | 10.02 | -27.59 |
Income Tax Expense/Benefit |
100.00%
-
|
0.902 | 0.905 | 1.308 | - |
Income/Loss From Continuing Operations After Tax |
6.06%
-10.22
|
-10.88 | -18.20 | 8.71 | -27.59 |
Net Income/Loss
|
6.06%
-10.22
|
-10.88 | -18.20 | 8.71 | -27.59 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
146.87K%
52.17
|
0.0355 | 51.78 | 51.67 | 51.65 |
Diluted Average Shares |
146.87K%
52.17
|
0.0355 | 51.78 | 61.04 | 51.65 |
Basic Earnings Per Share |
4.76%
-0.20
|
-0.21 | -0.35 | 0.17 | -0.53 |
Diluted Earnings Per Share |
4.76%
-0.20
|
-0.21 | -0.35 | 0.14 | -0.53 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):